Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

SHE:002653 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	46,300	36,883	25,545	23,695	21,747	18,638
Market Cap Growth	40.91%	44.38%	7.81%	8.96%	16.68%	-14.41%
Enterprise Value	47,210	37,658	26,256	25,227	22,521	19,066
Last Close Price	41.60	33.00	22.72	21.84	19.79	16.76
PE Ratio	135.17	93.27	86.56	85.52	63.02	29.28
Forward PE	82.38	58.20	62.99	69.53	62.77	23.76
PS Ratio	11.99	9.91	7.61	7.86	7.84	5.60
PB Ratio	11.25	8.78	6.13	7.56	7.45	6.53
P/TBV Ratio	16.10	12.56	7.45	10.18	10.07	8.10
P/FCF Ratio	-	26513.20	436.15	-	-	-
P/OCF Ratio	115.36	83.44	56.82	250.62	607.43	90.39
EV/Sales Ratio	12.23	10.12	7.83	8.37	8.12	5.73
EV/EBITDA Ratio	105.38	75.57	48.24	79.50	122.44	57.27
EV/EBIT Ratio	240.22	143.72	79.19	178.20	598.98	83.50
EV/FCF Ratio	-1261.76	27070.49	448.29	-	-	-
Debt / Equity Ratio	0.54	0.46	0.43	0.67	0.43	0.38
Debt / EBITDA Ratio	4.93	3.76	3.28	6.48	6.55	3.23
Debt / FCF Ratio	-	1373.28	30.84	-	-	-
Asset Turnover	0.56	0.55	0.53	0.55	0.56	0.66
Inventory Turnover	3.66	3.84	3.10	3.05	3.91	5.17
Quick Ratio	1.64	1.48	1.50	1.09	0.81	1.04
Current Ratio	1.91	1.74	1.76	1.38	1.02	1.22
Return on Equity (ROE)	10.05%	11.14%	8.09%	12.94%	17.93%	22.98%
Return on Assets (ROA)	1.78%	2.44%	3.26%	1.60%	0.47%	2.84%
Return on Capital (ROIC)	1.94%	2.71%	3.69%	1.88%	0.58%	3.86%
Return on Capital Employed (ROCE)	3.60%	5.00%	6.40%	3.10%	1.10%	7.00%
Earnings Yield	0.76%	1.07%	1.16%	1.17%	1.59%	3.42%
FCF Yield	-0.08%	0.00%	0.23%	-2.56%	-3.07%	-2.12%
Dividend Yield	0.99%	1.26%	0.88%	-	0.94%	2.22%
Payout Ratio	163.76%	106.72%	14.43%	89.32%	123.52%	20.54%
Buyback Yield / Dilution	0.61%	-3.37%	-2.57%	1.17%	0.07%	-0.50%
Total Shareholder Return	1.60%	-2.11%	-1.69%	1.17%	1.00%	1.72%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.